Adolescents who smoke e-cigarettes are exposed to significant levels of potentially cancer-causing chemicals also found in tobacco cigarettes, even when the e-cigarettes do not contain nicotine, according to a study by UC San Francisco researchers.
"Our study showed that there are toxic chemicals found in the bodies of teens who use e-cigarettes," explained senior author Danielle Ramo, PhD, an associate professor of psychiatry at UCSF. "Regardless of whether these products might help adults quit smoking, this study provides evidence that no teens should be vaping."
For the study, published March 5, 2018, in Pediatrics, researchers analyzed urine from a group of adolescents with an average age of 16.4 years. Sixty-seven used e-cigarettes only and 17 used both e-cigarettes and traditional tobacco cigarettes. They were compared with a control group of 20 non-smoking teens.
Levels of toxic organic compounds were up to three times higher on average in the e-cigarette users compared with the controls. In teenagers who used both e-cigarettes and tobacco cigarettes, levels of toxic compounds were up to three times higher than in e-cigarette users only.
"Teenagers need to be warned that the vapor produced by e-cigarettes is not harmless water vapor, but actually contains some of the same toxic chemicals found in smoke from traditional cigarettes," said lead author Mark L. Rubinstein, MD, a professor of pediatrics at UCSF. "Teenagers should be inhaling air, not products with toxins in them."
It was the first known study to report on the presence of potentially cancer-causing compounds in the bodies of adolescents who use e-cigarettes. The list of compounds included acrylonitrile, acrolein, propylene oxide, acrylamide and crotonaldehyde.
Toxic byproducts found even in adolescents who use e-cigarettes without nicotine
Rubinstein noted that some of the toxic chemicals were found in the bodies of teens who used flavored e-cigarettes without nicotine. He explained that propylene glycol and glycerin, which are used to keep the products smoked in e-cigarettes in liquid form, are approved by the Food and Drug Administration as safe at room temperature. “But when they’re heated to the high temperatures required for vaporization, they can produce toxic substances that are potentially carcinogenic,” he said.
"E-cigarettes are marketed to adults who are trying to reduce or quit smoking as a safer alternative to cigarettes,” added Rubinstein. “While they may be beneficial to adults as a form of harm reduction, kids should not be using them at all."
The study was funded by the National Institutes of Health grant numbers R21DA040718, P50 CA180890, P30 DA012393, S10 RR026437 and TRDRP 24XT-0007.
About UCSF Psychiatry
The UCSF Department of Psychiatry and the Langley Porter Psychiatric Institute are among the nation's foremost resources in the fields of child, adolescent, adult, and geriatric mental health. Together they constitute one of the largest departments in the UCSF School of Medicine and the UCSF Weill Institute for Neurosciences, with a mission focused on research (basic, translational, clinical), teaching, patient care and public service.
UCSF Psychiatry conducts its clinical, educational and research efforts at a variety of locations in Northern California, including UCSF campuses at Parnassus Heights, Mission Bay and Laurel Heights, UCSF Medical Center, UCSF Benioff Children's Hospitals, Zuckerberg San Francisco General Hospital and Trauma Center, the San Francisco VA Health Care System and UCSF Fresno.
About the UCSF Weill Institute for Neurosciences
The UCSF Weill Institute for Neurosciences, established by the extraordinary generosity of Joan and Sanford I. "Sandy" Weill, brings together world-class researchers with top-ranked physicians to solve some of the most complex challenges in the human brain.
The UCSF Weill Institute leverages UCSF’s unrivaled bench-to-bedside excellence in the neurosciences. It unites three UCSF departments—Neurology, Psychiatry, and Neurological Surgery—that are highly esteemed for both patient care and research, as well as the Neuroscience Graduate Program, a cross-disciplinary alliance of nearly 100 UCSF faculty members from 15 basic-science departments, as well as the UCSF Institute for Neurodegenerative Diseases, a multidisciplinary research center focused on finding effective treatments for Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, and other neurodegenerative disorders.
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences; and a preeminent biomedical research enterprise. It also includes UCSF Health, which comprises top-ranked hospitals – UCSF Medical Center and UCSF Benioff Children’s Hospitals in San Francisco and Oakland – and other partner and affiliated hospitals and healthcare providers throughout the Bay Area.